Sponsor Pipeline

Healionics Corporation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-14 NCT07557862
Multi-Site STARgraft (10401) Trial		 Enrollment increased: 75 -> 111 participants
2026-08-14 NCT07557862
Multi-Site STARgraft (10401) Trial		 Trial sites expanded: 1 -> 7 locations
Active Trials by Phase
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07555717 STARgraft (10401) Pilot End Stage Kidney Disease (ESRD) Recruiting
NCT05729620 Evaluation of STARgraft-3 for Hemodialysis End Stage Renal Disease Active, Not Recruiting
NCT07557862 Multi-Site STARgraft (10401) Trial End Stage Renal Disease (ESRD) Not Yet Recruiting
Disease Areas
Chronic Kidney Disease (3)
Get alerts when Healionics Corporation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free